Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
about
Estimated daily intake of phthalates in occupationally exposed groupsUrinary phthalate metabolite concentrations among workers in selected industries: a pilot biomonitoring studyUrinary phthalate metabolites and semen quality: a review of a potential biomarker of susceptibilityBiomarkers of exposure to triclocarban in urine and serumConcentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. malesDetox diets for toxin elimination and weight management: a critical review of the evidenceExposure to lipophilic chemicals as a cause of neurological impairments, neurodevelopmental disorders and neurodegenerative diseasesMechanisms mediating environmental chemical-induced endocrine disruption in the adrenal glandLipophilic chemical exposure as a cause of cardiovascular diseaseUrinary concentrations of phthalates in couples planning pregnancy and its association with 8-hydroxy-2'-deoxyguanosine, a biomarker of oxidative stress: longitudinal investigation of fertility and the environment studyExposure to endocrine disrupters and nuclear receptor gene expression in infertile and fertile women from different Italian areasRelationship of urinary phthalate metabolites with serum thyroid hormones in pregnant women and their newborns: a prospective birth cohort in TaiwanInterpreting variability in population biomonitoring data: Role of elimination kineticsAssociation of diethylhexyl phthalate with obesity-related markers and body mass change from birth to 3 months of agePhthalates Biomarker Identification and Exposure Estimates in a Population of Pregnant Women.Integrating biomonitoring exposure data into the risk assessment process: phthalates [diethyl phthalate and di(2-ethylhexyl) phthalate] as a case study.Bisphenol A in 24 h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation.What additional factors beyond state-of-the-art analytical methods are needed for optimal generation and interpretation of biomonitoring data?Exposure Marker Discovery of Phthalates Using Mass Spectrometry.In Utero and Lactational Exposure Study in Rats to Identify Replacements for Di(2-ethylhexyl) Phthalate.Human body burdens of chemicals used in plastic manufacture.Association between maternal exposure to di(2-ethylhexyl) phthalate and reproductive hormone levels in fetal blood: the Hokkaido study on environment and children's health.The association between urinary phthalates and lung function.Children's phthalate intakes and resultant cumulative exposures estimated from urine compared with estimates from dust ingestion, inhalation and dermal absorption in their homes and daycare centers.Diethylhexyl phthalates is associated with insulin resistance via oxidative stress in the elderly: a panel study.Oxidative metabolites of diisononyl phthalate as biomarkers for human exposure assessment.Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolitesInfluence of phthalates on cytokine production in monocytes and macrophages: a systematic review of experimental trials.Phthalates and human healthInfluence of phthalates on in vitro innate and adaptive immune responses.Phthalates Are Metabolised by Primary Thyroid Cell Cultures but Have Limited Influence on Selected Thyroid Cell Functions In VitroIn vitro metabolites of di-2-ethylhexyl adipate (DEHA) as biomarkers of exposure in human biomonitoring applications.Endocrine disruption: In silico perspectives of interactions of di-(2-ethylhexyl)phthalate and its five major metabolites with progesterone receptor.Exposure assessment issues in epidemiology studies of phthalates.Modeling Human Exposure to Phthalate Esters: A Comparison of Indirect and Biomonitoring Estimation Methods.Human exposure assessment to environmental chemicals using biomonitoring.Possible impact of phthalates on infant reproductive health.The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice.Peroxisome proliferator-activated receptors as mediators of phthalate-induced effects in the male and female reproductive tract: epidemiological and experimental evidencePhthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations.
P2860
Q23911337-4F77DFF8-CF13-4391-95CB-7F1528879610Q23911345-408F564F-A519-4469-8E3E-0767E653FC4DQ23920609-7B8DDD37-A439-4EE6-AED2-24AEA449B825Q23923923-0A7FD678-A057-4FEB-BF75-097CCFC904FCQ24672743-89414928-5966-4FE8-A191-65DCD044F64AQ28254132-2058AA4C-E70F-45E1-BC0F-8E68C59D6A46Q28382950-1D71F4B0-EDAA-437A-9F5E-D277CC3DEE65Q28389245-712AE287-BED5-4398-9927-597DF33C1EBDQ28389844-D0D74371-ABC8-4BF3-BCF6-ED5943D05370Q28392837-64D4D74C-0780-48F6-9256-EC5025D0C091Q28396629-707CA686-47C2-4417-A822-29FC00A2DF13Q28547843-E4124B2A-7482-4B84-9660-11CD1BD81759Q28950877-8DE6DDE2-940C-4E38-AD0A-48C55516E7EFQ29109840-781FCDDC-1A43-4523-94D0-D88ACD394F0DQ30435244-715CF967-9B02-46D5-BDA9-DF87B088D028Q31077492-37096DBD-1174-44AF-B549-FDE9557D5E24Q33454779-8711432E-3701-41FA-9569-C057387CC721Q33519535-FC59ACBE-A1CA-4080-B681-9BFDD3F9CB74Q33738123-74D3F79A-0075-4A1C-B5A5-A84DFA83766FQ33819054-3B3BEB5A-E54C-434B-8F23-CA0712DCB59CQ33862203-5F7491E8-93B5-45DA-836B-40908B9F06A3Q34306861-14954D71-54C8-446A-848A-9C50C45B533FQ34408276-744CE188-A047-4742-908C-D0EFDB4BCA5FQ34693145-23BF6599-C0DA-446B-921A-4DDF1F84A90CQ34971038-7ACCC9BF-F5D3-4923-8AA3-93FA1117F5D7Q35001767-C3CA7DAE-4CF6-4C53-8FC6-33B8383A1381Q35039257-22EE3358-021B-4894-AB17-BAF84ACA82A9Q35219703-ADF9C15D-89AE-4ED6-96D0-7836BF35E9A8Q35502266-3BDC78A7-28E0-4735-9FDD-740AC7F0B6D1Q35674351-21F17FC8-4E7D-4ED9-BA57-C2BB8A5E1BFBQ35960582-CFFD6175-F145-453F-B2C6-432B43E8785DQ36003718-1063B163-649D-4A04-A601-2FE7D3F6CA2AQ36158390-18DE2984-4CDE-4832-92D5-8D969BE9824AQ36289216-F46A061A-5BD3-469C-980A-2F73474781F7Q36317499-AE0DB7B0-DF26-4AEA-BD09-03EE338020B1Q36391067-24630CFD-A005-4A16-9660-2BA54BF57C1AQ36391070-329B41E4-EBB1-496F-B7CA-720191400009Q36397694-19D0FFB4-D2D6-4BF9-A8DD-D088977B183DQ36426777-5DDDB619-BF84-495C-86BF-FCFA9BFC14BBQ36490867-FB84B168-CD08-4860-983B-60B2D76677A8
P2860
Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Di(2-ethylhexyl)phthalate (DEH ...... se of deuterium-labelled DEHP.
@en
type
label
Di(2-ethylhexyl)phthalate (DEH ...... se of deuterium-labelled DEHP.
@en
prefLabel
Di(2-ethylhexyl)phthalate (DEH ...... se of deuterium-labelled DEHP.
@en
P1476
Di(2-ethylhexyl)phthalate (DEH ...... se of deuterium-labelled DEHP.
@en
P2093
Hermann M Bolt
Jürgen Angerer
P2888
P304
P356
10.1007/S00204-003-0522-3
P577
2003-10-24T00:00:00Z